AP NEWS

Horizon Pharma plc to Present at the 37th Annual J.P. Morgan Healthcare Conference

December 17, 2018

DUBLIN--(BUSINESS WIRE)--Dec 17, 2018--Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the 37 th Annual J.P. Morgan Healthcare Conference. Timothy P. Walbert, chairman, president and chief executive officer, will present at 4:30 p.m. PT on Jan. 8, 2019.

The conference presentation will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005196/en/

CONTACT: Investors:

Tina Ventura

Senior Vice President

Investor Relations

investor-relations@horizonpharma.comRuth Venning

Executive Director

Investor Relations

investor-relations@horizonpharma.comU.S. Media:

Geoff Curtis

Executive Vice President

Corporate Affairs & Chief Communications Officer

media@horizonpharma.comIreland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

KEYWORD: UNITED STATES EUROPE NORTH AMERICA CALIFORNIA NEW YORK IRELAND

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Horizon Pharma plc

Copyright Business Wire 2018.

PUB: 12/17/2018 08:00 AM/DISC: 12/17/2018 08:01 AM

http://www.businesswire.com/news/home/20181217005196/en

AP RADIO
Update hourly